Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Regulatory News (TM17)

  • There is currently no data for TM17

Director/PDMR Shareholding

14 Feb 2024 13:00

RNS Number : 1545D
Team17 Group PLC
14 February 2024
 

14 February 2024

 

Team 17 Group plc

("Team17" or the "Company")

 

Director / PDMR Shareholding

 

On 13 February 2024, the Company was notified by Penny Judd, a non-executive director of the Company, that, on 12 February 2024, the 24,242 ordinary shares of £0.01 each in the Company ("Ordinary Shares") held by her were the subject of an account transfer at nil consideration.

 

Penny Judd's beneficial interest in Ordinary Shares did not change as a result of this transfer and remains at 77,717 Ordinary Shares representing 0.05 per cent. of the issued Ordinary Shares.

 

Enquiries

Team17 Group plc

Steve Bell, Chief Executive Officer

Mark Crawford, Chief Financial Officer

James Targett, Group Investor Relations Director

Via Vigo Consulting

 

 

Houlihan Lokey (Nominated Adviser)

Tim Richardson

 

+44 (0) 20 7839 3355

 

 

Berenberg (Joint Broker)

Ben Wright / Toby Flaux / Marie Moy / Alix Mecklenburg-Solodkoff

 

+44 (0) 20 3207 7800

 

Peel Hunt (Joint Broker)

Neil Patel / Paul Gillam / Richard Chambers / James Smith

 

+44 (0) 20 7418 8900

 

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Fiona Hetherington / Aisling Fitzgerald

team17@vigoconsulting.com

 

+44 (0) 20 7390 0233

 

About Team17

Team17 Group plc is a global provider of games entertainment to a broad audience. The Group now includes a games entertainment label and creative partner for indie developers, a leading developer of educational apps, targeting children under the age of eight and a leading working simulation games developer and publisher.

Visit www.team17.com for more info

 

 

The Company publicly discloses the following notification pursuant to the UK Market Abuse Regulations:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Penny Judd

2

 

Reason for the notification

 

a)

 

Position/status

  

Non-Executive Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Team17 Group plc

b)

LEI

 

2138006EUUCCL4ZI5E51

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of £0.01 each in the Company ("Ordinary Shares")

 

 

ISIN: GB00BYVX2X20

b)

 

Nature of the transaction

Transfer of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

NA

24,242

 

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

 Aggregated Price(s)

 

Aggregated Volume(s)

NA

24,242

e)

 

Date of the transaction

12 February 2024

f)

 

Place of the transaction

Off Market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQKQBPBBKDKBD
Date   Source Headline
21st Nov 20194:53 pmRNSProposed Accelerated Bookbuild in Team17 Group PLC
15th Nov 20197:00 amRNSAppointment of Interim Chief Financial Officer
4th Nov 20197:00 amRNSTrading Update
31st Oct 20192:00 pmRNSDirectorate Change
10th Sep 20197:00 amRNSHalf year Results
3rd Sep 20197:00 amRNSAppointment of Non-Executive Director
5th Aug 20197:00 amRNSNotice of Results
28th Jun 20194:16 pmRNSHolding(s) in Company
27th Jun 20193:53 pmRNSHolding(s) in Company
21st Jun 20193:00 pmRNSHoldings in Company
19th Jun 20195:15 pmRNSHoldings in Company
19th Jun 20191:50 pmRNSHoldings in Company
18th Jun 20197:00 amRNSPre-close Trading Update
17th Jun 20197:00 amRNSHolding(s) in Company
30th May 20191:45 pmRNSHoldings in Company
28th May 20193:17 pmRNSHolding(s) in Company
24th May 201910:23 amRNSHolding(s) in Company
24th May 20197:00 amRNSResult of ABB in Team17 Group PLC
23rd May 20194:37 pmRNSProposed Accelerated Bookbuild in Team17 Group PLC
8th May 20191:00 pmRNSResult of AGM
5th Apr 20197:00 amRNSPosting of Annual Report and Notice of AGM
3rd Apr 20194:41 pmRNSSecond Price Monitoring Extn
3rd Apr 20194:36 pmRNSPrice Monitoring Extension
28th Mar 20195:12 pmRNSHolding(s) in Company
28th Mar 20195:10 pmRNSHolding(s) in Company
27th Mar 20197:00 amRNSResult of Secondary Placing in Team17 Group PLC
26th Mar 20194:35 pmRNSProposed Secondary Placing in Team17 Group PLC
19th Mar 20197:00 amRNSUnaudited Final Results
25th Feb 20197:00 amRNSAppointment of Non-Executive Director
13th Feb 20193:45 pmRNSHoldings in Company
30th Jan 20194:33 pmRNSHolding(s) in Company
29th Jan 20197:00 amRNSTrading Update
18th Dec 20187:00 amRNSGrant of Options
7th Dec 20187:00 amRNSGenesis Alpha One Launch
23rd Oct 20187:00 amRNSDirectorate Change
11th Sep 20187:00 amRNSInterim Results
4th Sep 20187:00 amRNSTeam17 launches 100th game
1st Aug 20187:00 amRNSNotice of Results
18th Jul 20187:00 amRNSTrading Update
13th Jun 20187:00 amRNSAnnouncement of Overcooked 2 Launch
24th May 20183:45 pmRNSHoldings in Company
23rd May 20187:00 amRNSAdmission to Trading & First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.